The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

In a proof-of-concept study, scientists have shown that flossing your teeth could be a way to deliver vaccinations that ...

ALPENA — Local health department officials say that mercury-based preservatives used in influenza immunizations do not affect long-term health, especially in children. U.S. Health and Human Services ...

Vaccine Platform for Pandemic Preparedness and Global Immunization ATLANTA, GA - July 28, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...

Large-scale screenings conducted in healthcare facilities, including the Pakistan Kidney and Liver Institute, have found a 42 ...

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...

HHS announced on Wednesday that it has adopted a recommendation from a CDC committee to remove thimerosal from all influenza vaccines.

Despite advancements, hepatitis remains a threat, fueled by unexpected sources like tattoos and unsafe medical practices. Dr.

Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held ...

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...